一种用于纵向AMD随访的多模态工具增强代理,支持基于证据的临床决策辅助
A multimodal tool-augmented agent for evidence-based clinical decision support in longitudinal AMD follow-up
研究开发了AMDagent,一种基于证据的临床代理,结合定量影像分析和指南检索,生成结构化的临床决策支持输出。在20个病例的初步评估中,92.0%的决策支持单元被专家评定为临床适宜,83.3%的重大临床声明得到了工具衍生的定量测量或检索指南证据的支持。
介绍了基于证据的多模态辅助决策支持系统,有助于提高AMD管理的透明度和可审计性。
- Article
- Open access
- Published: 03 November 2026
npj Digital Medicine (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Clinical management of age-related macular degeneration (AMD) requires longitudinal decisions on disease activity, treatment response, and anti-VEGF injection intervals. These decisions depend on integrating multimodal retinal imaging findings across visits, yet manual synthesis is time-consuming and may omit relevant information, limiting transparency and consistency in follow-up planning. Large language models (LLMs) have been explored to summarize longitudinal AMD information, but existing approaches may lack explicit quantitative grounding and evidence attribution, reducing their auditability in clinical decision support. To address these limitations, we developed AMDagent, an evidence-grounded clinical agent that integrates quantitative imaging analysis with guideline retrieval to generate structured, clinician-facing decision-support outputs. The system links longitudinal imaging findings to actionable management considerations while preserving traceable evidence sources. In a 20-case proof-of-concept evaluation of curated longitudinal AMD cases, AMDagent was rated clinically appropriate in 92.0% of predefined decision-support units under expert adjudication. In addition, 83.3% of audited major clinical claims were explicitly grounded in tool-derived quantitative measurements and/or retrieved guideline evidence, enabling clinician verification. These preliminary findings suggest that evidence-grounded, clinician-facing agents may support more transparent and auditable longitudinal AMD decision support, although larger prospective multi-center studies are needed to assess generalizability and clinical utility.
Acknowledgements
The authors have no acknowledgments to declare.
Funding
This work was supported by the Frontier Technologies R&D Program of Jiangsu No. BF2026681, and in part by the National Natural Science Foundation of China under Grant Nos. 62671580, 62371442, and 82201195. The funders had no role in the study design, data collection and analysis, preparation of the manuscript, or decision to submit the manuscript for publication.
Author information
Authors and Affiliations
School of Biomedical Engineering, Nanjing University, Suzhou, China
Tao Chen & Jiong Zhang
Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
Tao Chen
Eye Center of Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
Kai Jin
Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, China
Kai Jin
Authors
- Tao Chen
- Kai Jin
- Jiong Zhang
Corresponding authors
Correspondence to Kai Jin or Jiong Zhang.
Ethics declarations
Competing interests
K.J. is an Associate Editor of npj Digital Medicine and was not involved in the selection of peer reviewers for this manuscript nor in any subsequent editorial decisions. The other authors have no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Chen, T., Jin, K. & Zhang, J. A multimodal tool-augmented agent for evidence-based clinical decision support in longitudinal AMD follow-up. npj Digit. Med. (2026). https://doi.org/10.1038/s41746-026-03412-9
Received: 01 April 2026
Accepted: 04 October 2026
Published: 03 November 2026
DOI: https://doi.org/10.1038/s41746-026-03412-9
来源:Nature 健康护理主题 · nature.com